Jeevan Kumar

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Sebastian Grosicki, Maryana Simonova, Ivan Špıčka et al. · The Lancet · 2020 · 324 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Synthesis and structure–activity relationship of potent, selective and orally active anthranilamide-based factor Xa inhibitors: Application of weakly basic sulfoximine group as novel S4 binding element

Vrajesh B. Pandya, Mukul R. Jain, Ganes Chakrabarti et al. · European Journal of Medicinal Chemistry · 2012 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Thalidomide in Patients with Transfusion-Dependent E-Beta Thalassemia Refractory to Hydroxyurea: A Single-Center Experience

Arijit Nag, Vivek Radhakrishnan, Jeevan Kumar et al. · Indian Journal of Hematology and Blood Transfusion · 2020 · 28 citations · Full text

Medicine, Hematology, Pharmacotherapy +8

FxCycle™ Based Ploidy Correlates with Cytogenetic Ploidy in B‐Cell Acute Lymphoblastic Leukemia and Is Able to Detect the Aneuploid Minimal Residual Disease Clone

Nishit Gupta, Mayur Parihar, Sambhunath Banerjee et al. · Cytometry Part B Clinical Cytometry · 2019 · 24 citations · Full text

Medicine, Hematology, Oncology +17

Bioactivity Assessment of Indian Origin—Mangrove Actinobacteria against Candida albicans

Jeevan Kumar, Ajitha Gomathi, Vı́tor Vasconcelos et al. · Marine Drugs · 2018 · 23 citations · Full text

Life Sciences, Marine Sciences, Microbiology +16